source: FOIAVistA/trunk/r/DRG_GROUPER-ICD--ICPT/ICD1831F.m@ 1801

Last change on this file since 1801 was 628, checked in by George Lilly, 15 years ago

initial load of FOIAVistA 6/30/08 version
File size: 8.6 KB
Line 
1ICD1831F ;ALB/RBS - FY 2008 DRG UPDATE ; 11/1/07 11:36am
2 ;;18.0;DRG Grouper;**31**;Oct 13, 2000;Build 7
3 ;
4 Q
5 ;
6MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS^
7 ;;640^10^MED^NUTRITIONAL & MISC METABOLIC DISORDERS W MCC^0.9793^4.1^
8 ;;641^10^MED^NUTRITIONAL & MISC METABOLIC DISORDERS W/O MCC^0.7248^3.1^
9 ;;642^10^MED^INBORN ERRORS OF METABOLISM^1.0616^3.8^
10 ;;643^10^MED^ENDOCRINE DISORDERS W MCC^1.3926^6.0^
11 ;;644^10^MED^ENDOCRINE DISORDERS W CC^1.0638^4.3^
12 ;;645^10^MED^ENDOCRINE DISORDERS W/O CC/MCC^0.8310^3.2^
13 ;;652^11^SURG^KIDNEY TRANSPLANT^3.0654^6.6^
14 ;;653^11^SURG^MAJOR BLADDER PROCEDURES W MCC^4.5710^13.3^
15 ;;654^11^SURG^MAJOR BLADDER PROCEDURES W CC^3.1860^8.8^
16 ;;655^11^SURG^MAJOR BLADDER PROCEDURES W/O CC/MCC^2.7075^5.8^
17 ;;656^11^SURG^KIDNEY & URETER PROCEDURES FOR NEOPLASM W MCC^2.6603^8.4^
18 ;;657^11^SURG^KIDNEY & URETER PROCEDURES FOR NEOPLASM W CC^1.8997^5.1^
19 ;;658^11^SURG^KIDNEY & URETER PROCEDURES FOR NEOPLASM W/O CC/MCC^1.6556^3.3^
20 ;;659^11^SURG^KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC^2.8119^8.2^
21 ;;660^11^SURG^KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC^2.0605^4.8^
22 ;;661^11^SURG^KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W/O CC/MCC^1.4004^2.6^
23 ;;662^11^SURG^MINOR BLADDER PROCEDURES W MCC^2.0375^7.3^
24 ;;663^11^SURG^MINOR BLADDER PROCEDURES W CC^1.4254^3.6^
25 ;;664^11^SURG^MINOR BLADDER PROCEDURES W/O CC/MCC^1.0388^1.6^
26 ;;665^11^SURG^PROSTATECTOMY W MCC^2.1393^9.3^
27 ;;666^11^SURG^PROSTATECTOMY W CC^1.4691^4.3^
28 ;;667^11^SURG^PROSTATECTOMY W/O CC/MCC^0.9335^2.0^
29 ;;668^11^SURG^TRANSURETHRAL PROCEDURES W MCC^1.7208^6.3^
30 ;;669^11^SURG^TRANSURETHRAL PROCEDURES W CC^1.2079^3.1^
31 ;;670^11^SURG^TRANSURETHRAL PROCEDURES W/O CC/MCC^0.8838^1.9^
32 ;;671^11^SURG^URETHRAL PROCEDURES W CC/MCC^1.2808^3.9^
33 ;;672^11^SURG^URETHRAL PROCEDURES W/O CC/MCC^0.8422^1.9^
34 ;;673^11^SURG^OTHER KIDNEY & URINARY TRACT PROCEDURES W MCC^2.5235^6.0^
35 ;;674^11^SURG^OTHER KIDNEY & URINARY TRACT PROCEDURES W CC^2.1024^4.0^
36 ;;675^11^SURG^OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC^1.7196^1.4^
37 ;;682^11^MED^RENAL FAILURE W MCC^1.4664^5.3^
38 ;;683^11^MED^RENAL FAILURE W CC^1.1942^4.5^
39 ;;684^11^MED^RENAL FAILURE W/O CC/MCC^0.9835^3.1^
40 ;;685^11^MED^ADMIT FOR RENAL DIALYSIS^0.8599^2.4^
41 ;;686^11^MED^KIDNEY & URINARY TRACT NEOPLASMS W MCC^1.4513^6.0^
42 ;;687^11^MED^KIDNEY & URINARY TRACT NEOPLASMS W CC^1.1147^4.0^
43 ;;688^11^MED^KIDNEY & URINARY TRACT NEOPLASMS W/O CC/MCC^0.8577^2.5^
44 ;;689^11^MED^KIDNEY & URINARY TRACT INFECTIONS W MCC^1.0587^5.0^
45 ;;690^11^MED^KIDNEY & URINARY TRACT INFECTIONS W/O MCC^0.8000^3.6^
46 ;;691^11^MED^URINARY STONES W ESW LITHOTRIPSY W CC/MCC^1.1508^3.0^
47 ;;692^11^MED^URINARY STONES W ESW LITHOTRIPSY W/O CC/MCC^0.9457^1.8^
48 ;;693^11^MED^URINARY STONES W/O ESW LITHOTRIPSY W MCC^1.0459^3.9^
49 ;;694^11^MED^URINARY STONES W/O ESW LITHOTRIPSY W/O MCC^0.7110^2.0^
50 ;;695^11^MED^KIDNEY & URINARY TRACT SIGNS & SYMPTOMS W MCC^0.9422^4.3^
51 ;;696^11^MED^KIDNEY & URINARY TRACT SIGNS & SYMPTOMS W/O MCC^0.6276^2.6^
52 ;;697^11^MED^URETHRAL STRICTURE^0.7223^2.4^
53 ;;698^11^MED^OTHER KIDNEY & URINARY TRACT DIAGNOSES W MCC^1.3017^5.1^
54 ;;699^11^MED^OTHER KIDNEY & URINARY TRACT DIAGNOSES W CC^1.0352^3.8^
55 ;;700^11^MED^OTHER KIDNEY & URINARY TRACT DIAGNOSES W/O CC/MCC^0.8232^2.7^
56 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES W CC/MCC^1.5521^3.5^
57 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES W/O CC/MCC^1.1858^2.0^
58 ;;709^12^SURG^PENIS PROCEDURES W CC/MCC^1.6134^3.6^
59 ;;710^12^SURG^PENIS PROCEDURES W/O CC/MCC^1.2986^1.5^
60 ;;711^12^SURG^TESTES PROCEDURES W CC/MCC^1.6051^5.3^
61 ;;712^12^SURG^TESTES PROCEDURES W/O CC/MCC^1.0842^2.1^
62 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY W CC/MCC^0.9850^2.9^
63 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY W/O CC/MCC^0.6710^1.7^
64 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC FOR MALIGNANCY W CC/MCC^1.5300^3.8^
65 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC FOR MALIGNANCY W/O CC/MCC^1.1310^1.3^
66 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC EXC MALIGNANCY W CC/MCC^1.5653^5.0^
67 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC EXC MALIGNANCY W/O CC/MCC^1.0329^2.1^
68 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC^1.2827^5.6^
69 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM W CC^1.0603^4.2^
70 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM W/O CC/MCC^0.7677^2.5^
71 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY W MCC^0.9071^4.4^
72 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY W/O MCC^0.6886^2.8^
73 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM W MCC^1.0083^5.1^
74 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM W/O MCC^0.7241^3.3^
75 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES W CC/MCC^0.9542^3.7^
76 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES W/O CC/MCC^0.7058^2.4^
77 ;;734^13^SURG^PELVIC EVISCERATION, RAD HYSTERECTOMY & RAD VULVECTOMY W CC/MCC^2.0185^5.8^
78 ;;735^13^SURG^PELVIC EVISCERATION, RAD HYSTERECTOMY & RAD VULVECTOMY W/O CC/MCC^1.3798^3.0^
79 ;;736^13^SURG^UTERINE & ADNEXA PROC FOR OVARIAN OR ADNEXAL MALIGNANCY W MCC^3.2108^11.5^
80 ;;737^13^SURG^UTERINE & ADNEXA PROC FOR OVARIAN OR ADNEXAL MALIGNANCY W CC^2.1022^6.2^
81 ;;738^13^SURG^UTERINE & ADNEXA PROC FOR OVARIAN OR ADNEXAL MALIGNANCY W/O CC/MCC^1.6754^3.5^
82 ;;739^13^SURG^UTERINE,ADNEXA PROC FOR NON-OVARIAN/ADNEXAL MALIG W MCC^2.2081^7.9^
83 ;;740^13^SURG^UTERINE,ADNEXA PROC FOR NON-OVARIAN/ADNEXAL MALIG W CC^1.4577^4.4^
84 ;;741^13^SURG^UTERINE,ADNEXA PROC FOR NON-OVARIAN/ADNEXAL MALIG W/O CC/MCC^1.0308^2.8^
85 ;;742^13^SURG^UTERINE & ADNEXA PROC FOR NON-MALIGNANCY W CC/MCC^1.2422^3.5^
86 ;;743^13^SURG^UTERINE & ADNEXA PROC FOR NON-MALIGNANCY W/O CC/MCC^0.8672^2.1^
87 ;;744^13^SURG^D&C, CONIZATION, LAPARASCOPY & TUBAL INTERRUPTION W CC/MCC^1.1896^4.0^
88 ;;745^13^SURG^D&C, CONIZATION, LAPARASCOPY & TUBAL INTERRUPTION W/O CC/MCC^0.8660^2.1^
89 ;;746^13^SURG^VAGINA, CERVIX & VULVA PROCEDURES W CC/MCC^1.0488^3.0^
90 ;;747^13^SURG^VAGINA, CERVIX & VULVA PROCEDURES W/O CC/MCC^0.8499^1.7^
91 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^0.7916^1.5^
92 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES W CC/MCC^2.2813^7.1^
93 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES W/O CC/MCC^1.4993^2.6^
94 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W MCC^1.5596^6.4^
95 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC^1.1608^4.2^
96 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W/O CC/MCC^0.7702^2.5^
97 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM W MCC^1.4328^6.8^
98 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM W CC^1.1147^4.9^
99 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM W/O CC/MCC^0.9609^3.7^
100 ;;760^13^MED^MENSTRUAL & OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS W CC/MCC^0.6910^2.9^
101 ;;761^13^MED^MENSTRUAL & OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS W/O CC/MCC^0.5569^2.0^
102 ;;765^14^SURG^CESAREAN SECTION W CC/MCC^0.9943^4.1^
103 ;;766^14^SURG^CESAREAN SECTION W/O CC/MCC^0.7664^3.0^
104 ;;767^14^SURG^VAGINAL DELIVERY W STERILIZATION &/OR D&C^0.7246^2.5^
105 ;;768^14^SURG^VAGINAL DELIVERY W O.R. PROC EXCEPT STERIL &/OR D&C^1.7348^4.7^
106 ;;769^14^SURG^POSTPARTUM & POST ABORTION DIAGNOSES W O.R. PROCEDURE^1.9114^3.2^
107 ;;770^14^SURG^ABORTION W D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^0.7336^1.6^
108 ;;774^14^MED^VAGINAL DELIVERY W COMPLICATING DIAGNOSES^0.5914^2.6^
109 ;;775^14^MED^VAGINAL DELIVERY W/O COMPLICATING DIAGNOSES^0.4461^2.1^
110 ;;776^14^MED^POSTPARTUM & POST ABORTION DIAGNOSES W/O O.R. PROCEDURE^0.6460^2.6^
111 ;;777^14^MED^ECTOPIC PREGNANCY^0.7087^1.8^
112 ;;778^14^MED^THREATENED ABORTION^0.3744^2.0^
113 ;;779^14^MED^ABORTION W/O D&C^0.6013^1.7^
114 ;;780^14^MED^FALSE LABOR^0.2845^1.3^
115 ;;781^14^MED^OTHER ANTEPARTUM DIAGNOSES W MEDICAL COMPLICATIONS^0.5689^2.7^
116 ;;782^14^MED^OTHER ANTEPARTUM DIAGNOSES W/O MEDICAL COMPLICATIONS^0.4297^1.7^
117 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.4250^*^
118 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^4.6990^*^
119 ;;791^15^MED^PREMATURITY W MAJOR PROBLEMS^3.2093^*^
120 ;;792^15^MED^PREMATURITY W/O MAJOR PROBLEMS^1.9364^*^
121 ;;793^15^MED^FULL TERM NEONATE W MAJOR PROBLEMS^3.2966^*^
122 ;;794^15^MED^NEONATE W OTHER SIGNIFICANT PROBLEMS^1.1668^*^
123 ;;795^15^MED^NORMAL NEWBORN^0.1580^*^
124 ;;799^16^SURG^SPLENECTOMY W MCC^3.9513^10.7^
125 ;;800^16^SURG^SPLENECTOMY W CC^2.7617^6.4^
126 ;;801^16^SURG^SPLENECTOMY W/O CC/MCC^2.3252^3.7^
127 ;;802^16^SURG^OTHER O.R. PROC OF THE BLOOD & BLOOD FORMING ORGANS W MCC^2.7940^9.1^
128 ;;803^16^SURG^OTHER O.R. PROC OF THE BLOOD & BLOOD FORMING ORGANS W CC^1.8259^4.7^
129 ;;804^16^SURG^OTHER O.R. PROC OF THE BLOOD & BLOOD FORMING ORGANS W/O CC/MCC^1.4754^2.4^
130 ;;808^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W MCC^1.6171^6.0^
131 ;;809^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W CC^1.2031^3.9^
132 ;;EXIT
133 Q
Note: See TracBrowser for help on using the repository browser.